Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Filings indexed 1,205 across all filing types
Latest filing 2023-02-08 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has received an intimation from M/s. Link Intime India Private ....
Regulatory Filings Classification · 100% confidence The document text is extremely short (122 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not fit any specific report category and appears to be a regulatory or compliance-related filing with no detailed information. According to the rules, such minimal content defaults to Regulatory Filings (RNS).
2023-02-08 English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulation, 2015; the Board of Directors at its Meeting held today i.e. 7th February 2023 inter ....
Regulatory Filings
2023-02-07 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Lyka Labs Limited dated 7th February 2023, reporting the outcome of a Board Meeting. It includes unaudited standalone and consolidated financial results for the third quarter ended 31st December 2022, along with a limited review report. The document contains comprehensive financial data such as revenue, expenses, profit/loss figures, and notes explaining exceptional items and other financial details. The presence of quarterly financial results with substantive financial data and analysis indicates this is an Interim / Quarterly Report. It is not merely an announcement of a report or a certification, but contains actual financial statements and explanatory notes. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2023
2023-02-07 English
Outcome of Board Meeting
Regulatory Filings
2023-02-07 English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; the Board of Directors at its Meeting held today i.e. 7th February 2023 inter ....
Regulatory Filings
2023-02-07 English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 ,inter alia, to consider and approve A meeting of the Board of Directors ....
Regulatory Filings Classification · 100% confidence The document text is extremely short (112 characters) and contains only a digital signature with a date, without any substantive content, financial data, or report details. It does not contain any report, announcement, or detailed information. Given the lack of content, this is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2023-01-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.